Dear Medical and Scientific Colleagues:
It is our pleasure and privilege to welcome you to the 2nd Biennial International Congress on ATTR Amyloidosis (ICAA) Conference. From the moment you enter the Virtual Conference Center, you’ll spend two days engaging in a lively, interactive conference experience. We will begin with a foundational overview of ATTR-CM, reviewing best practices in diagnosis and treatment of the disease. Then we will move on to provide guidance on tracking disease progression, followed by a robust roundtable discussion on the latest clinical trial results in ATTR-CM.
In the afternoon, we will look at some cases and have a lively discussion. Finally, we will turn our attention to the future of ATTR-CM Management, exploring stabilizer and silencer combination therapy as well as other emerging therapies coming down the pipeline. You will have ample opportunities throughout the day to ask questions and get answers from our esteemed presenters.
As in any live conference venue, you will also find robust opportunities to interact with your colleagues beyond the educational sessions.
Once again, welcome! We hope you will enjoy this one-of-a-kind virtual conference, benefit from the learning opportunities, and gather many clinical pearls to “bring home” to your practice!
CO-CHAIRS
AGENDA
Select a session below to view more details.